How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

Background In breast cancer patients with nodal metastases at presentation, false-negative rates lower than 10 % have been demonstrated for sentinel node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) when three or more negative sentinel nodes (SLNs) are retrieved. However, the frequency with wh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2016-10, Vol.23 (11), p.3467-3474
Hauptverfasser:	Mamtani, Anita, Barrio, Andrea V., King, Tari A., Van Zee, Kimberly J., Plitas, George, Pilewskie, Melissa, El-Tamer, Mahmoud, Gemignani, Mary L., Heerdt, Alexandra S., Sclafani, Lisa M., Sacchini, Virgilio, Cody, Hiram S., Patil, Sujata, Morrow, Monica
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Axilla Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Breast Neoplasms - surgery Breast Oncology Chemotherapy, Adjuvant Female Humans Lymph Node Excision Lymphatic Metastasis Medicine Medicine & Public Health Middle Aged Neoadjuvant Therapy Neoplasm Staging Oncology Prospective Studies Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Sentinel Lymph Node - pathology Sentinel Lymph Node - surgery Sentinel Lymph Node Biopsy Surgery Surgical Oncology Triple Negative Breast Neoplasms - pathology Triple Negative Breast Neoplasms - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!